(Q50095736)

English

Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma

scientific article published on 19 October 2017

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

retrieved

24 February 2018

reference URL

http://europepmc.org/abstract/MED/29048973

editorial

0 references

title

Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

retrieved

24 February 2018

reference URL

http://europepmc.org/abstract/MED/29048973

language of work or name

English

0 references

publication date

19 October 2017

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

retrieved

24 February 2018

reference URL

http://europepmc.org/abstract/MED/29048973

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29048973%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 June 2020

volume

35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29048973%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 June 2020

issue

34

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29048973%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 June 2020

page(s)

3792-3793

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29048973%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 June 2020

Identifiers

DOI

10.1200/JCO.2017.75.2055

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29048973%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 June 2020

PubMed publication ID

29048973

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29048973

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29048973%20AND%20SRC:MED&resulttype=core&format=json

(Q50095736)

Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)